VIETER
VIETNAM MARKET INTELLIGENCE

Australia Endoscopic Spinal Surgery Industry

Australia Spinal Surgery Devices Market Analysis

The Australia Spinal Surgery Devices Market size is estimated at USD 399.02 million in 2025, and is expected to reach USD 478.28 million by 2030, at a CAGR of 3.69% during the forecast period (2025-2030).

The COVID-19 pandemic has significantly impacted the Australia Spinal Surgery Devices Market. For instance, as per a March 2020 update by the Spine Society of Australia, the Spine Society of Australia supported the Australian Government's decision to temporarily suspend elective surgery, except for urgent Category 2 procedures such as unstable cervical, thoracic, and lumbar fractures, and Category 1 surgery will continue, including surgical treatment of postoperative complications, other than planned revision surgeries. As a result, this reduced the total number of surgeries performed across Australia. Thus, the pandemic has resulted in lower demand for spinal surgery devices, thereby impacting the market growth.

Further, the growth of the market studied can be largely attributed to factors such as the increasing demand for minimally invasive surgical procedures, leading to an expansion of the endoscopic spinal surgery market, the increasing incidence of obesity, the aging population, and associated spine disorders. Continuous advancements in spinal surgery equipment, spine biologics, and spinal surgical instruments are also expected to provide a boost to the market over the forecast period. Additionally, increasing demand for spinal fusion devices and spine stabilization devices is driving the market's growth further. For instance, as per SpinalCure Australia 2020, each day, on average a person suffers from an injury requiring treatments such as spine implants, adding to the more than 20,000 people across Australia and millions around the world who live with the debilitating effects of a spinal cord injury. In addition, as per a November 2021 update by the Australian Institute of Health and Welfare, in June 2020, approximately 4.2 million people (16% of Australia's total population) were aged 65 and over. As the older population is more susceptible to spinal injuries and conditions, the demand for products in the cervical fusion market and for vertebral implants is set to increase over the coming years, thereby driving the market growth.

However, the high cost and time involved in treatment procedures and reimbursement issues are some of the major factors restraining the Australia Spinal Surgery Devices Market's growth.

Australia Spinal Surgery Devices Market Trends

Spinal Fusion is Expected to Hold a Significant Market Share

The growth of the spinal fusion devices segment is majorly driven by the increase in the geriatric population and the rise in the incidence of spinal disorders. For instance, according to the Australian Bureau of Statistics (ABS), the number of Australians aged 85 and over is expected to double by 2042, reaching almost 1 million people, according to the most recent population forecasts published in 2018. The population of Australia is expected to continue to age as a result of low fertility paired with rising life expectancy, with the number of people aged 65 and above expected to nearly double from 3.8 million in 2017 to between 6.4 million and 6.7 million in 2042. As this population is more prone to back pain and spinal conditions, the demand for procedures such as artificial disc replacement and devices like spinal fusion devices is likely to increase over the coming years, thereby boosting the segment growth. In addition, the expansion in indications for which spinal fusion surgery is performed, including in the cervical fusion market, boosts the market growth.These devices, including vertebral implants, spinal cage, and spine implants, are intended to treat disc degenerative diseases, spine injuries, and other disorders pertaining to the cervical, thoracic, and lumbar areas of the spine. Thus, the growing prevalence of these disorders is attributable to the large share of the segment.

Australia Spinal Surgery Devices Industry Overview

The Australian spine market is fragmented and competitive and consists of several major players. The key players in the market are focusing on strategic mergers and acquisitions to expand their product portfolios in areas such as spine implants and spinal instrumentation and strengthen their positions in the market. There are also devices that these companies continue to release, contributing to the market's potential growth. In terms of market share, a few of the major players are currently dominating the market. Some of the top spine companies 2023 currently dominating the market are Depuy Synthes Spine Inc. (Johnson & Johnson), Orthofix Holdings Inc., Medtronic PLC, NuVasive Inc., KARL STORZ, Evolution Surgical, Stryker Corporation, and Zimmer Holdings Inc.

Australia Spinal Surgery Devices Market Leaders

  1. Depuy Synthes Spine Inc. (Johnson & Johnson)

  2. Medtronic PLC

  3. NuVasive Inc

  4. Zimmer Holdings Inc

  5. Orthofix Holdings Inc

  6. *Disclaimer: Major Players sorted in no particular order

Australia Spinal Surgery Devices Market News

In October 2021, Stryker established a research and development laboratory in Queensland, Australia.

In July 2020, Joimax, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, entered a new partnership with the Australian medical device distributor, LifeHealthcare.